D-1501-2014 Class II Terminated

Recalled by Daiichi Sankyo Pharma Development — Edison, NJ

FDA drug recall D-1501-2014 was initiated by Daiichi Sankyo Pharma Development on July 12, 2014 and is designated Class II. Reason for recall: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping The recall status is terminated (terminated March 16, 2015). Affected quantity: 5 bottles.

Recall Details

Product Type
Drugs
Report Date
August 6, 2014
Initiation Date
July 12, 2014
Termination Date
March 16, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 bottles

Product Description

Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc. Parsippany, NJ 07054 NDC 65597-113-30

Reason for Recall

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Distribution Pattern

Nationwide

Code Information

Lot #213655B Exp - 12/31/2017